C

CytomX Therapeutics

150 employees

CytomX Therapeutics is a biotechnology company that focuses on developing proteolytically-activated antibodies.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Therapeutics
Health Care

Date founded

2008

Funding rounds raised

Total raised

$70M

from 11 investors over 11 rounds

C

CytomX Therapeutics raised $70M on June 16, 2015

Investors: Redmile Group, Tekla Capital Management, Wellington Management, Perceptive Advisors, Venrock and Casdin Capital, LLC

C

CytomX Therapeutics raised $20M on January 6, 2015

Investors: Third Rock Ventures and Canaan

C

CytomX Therapeutics raised $11M on July 31, 2012

Investors: Canaan and Third Rock Ventures

C

CytomX Therapeutics raised $30M on September 23, 2010

Investors: Third Rock Ventures

FAQ